Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma
Pediatr Blood Cancer. 2024 Dec 9:e31477. doi: 10.1002/pbc.31477. Online ahead of print. ABSTRACT BACKGROUND: Patients with relapsed rhabdomyosarcoma (RMS) are treated with varying approaches and …